disulfiram has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
Excerpt | Relevance | Reference |
---|---|---|
"Disulfiram (DSF) is a drug used to clinically control alcoholism that has recently been shown to be cytotoxic for multiple cancers." | 1.72 | Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin-proteasome pathway. ( Chen, C; Chen, Z; Huang, Y; Li, Y; Liu, X; Liu, Z; Nie, D; Sui, S; Tan, J; Wang, X; Yu, X; Yu, Z; Zeng, C; Zhong, M, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C | 1 |
Nie, D | 1 |
Huang, Y | 1 |
Yu, X | 1 |
Chen, Z | 1 |
Zhong, M | 1 |
Liu, X | 1 |
Wang, X | 1 |
Sui, S | 1 |
Liu, Z | 1 |
Tan, J | 1 |
Yu, Z | 1 |
Li, Y | 1 |
Zeng, C | 1 |
1 other study available for disulfiram and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin-proteasome pathway.
Topics: Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome; Disulfiram; Humans; Precursor T-Cell Lymphoblast | 2022 |